Mark Bodmer - Sep 11, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
CSO, President of R&D
Signature
/s/ Marella Thorell, Attorney-in-Fact for Mark Bodmer
Stock symbol
EVLO
Transactions as of
Sep 11, 2023
Transactions value $
$0
Form type
4
Date filed
9/13/2023, 08:55 PM
Previous filing
Aug 9, 2023
Next filing
Nov 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Award $0 +37.5K $0.00 37.5K Sep 11, 2023 Common Stock 37.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 The RSUs vest in three (3) substantially equal installments on each of November 1, 2023, February 1, 2024 and May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. These RSUs have no expiration date.